Cardiac rhythm management devices in patients with heart failure - preliminary results of the DIRECT HF international survey on patients' needs and perceptions

19 May 2025 (15:00 - 15:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Ms Rhonda Ellen Monroe

BOOST-Better Outcomes Optimal Scientific Therapies, Charlotte (United States of America)

4 More presentations in this session

Presentation thumbnail

Refining definitions of severe and advanced heart failure: insight from the swedish heart failure registry to optimize trial design and improve referral to advanced therapies

Doctor F. Guidetti (Bern, CH)

Abstract Slides Video

Presentation thumbnail

Association between neutrophil-to-lymphocyte ratio, exercise capacity and outcomes in patients with heart failure and reduced ejection fraction

Doctor E. Rodenas Alesina (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Sodium zirconium cyclosilicate for the management of hyperkalaemia in patients with heart failure with reduced ejection fraction - the REALIZE-K open-label run-in phase

Professor M. Petrie (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial

Doctor P. Tolomeo (Glasgow, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Advances in heart failure therapeutics

The Event

Event poster

Heart Failure 2025

19 May 2025 15:00 CET

You may be interested in

Congress Presentation

Patients’ and clinicians’ perspectives on heart failure care – key learnings from the DIRECT HF surveys

Congress Presentation

Cardiac rhythm management devices in patients with heart failure - preliminary results of the DIRECT HF international survey on healthcare professionals' educational needs

Congress Presentation

Welcome and introduction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources